These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder. Higgins ES J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377 [TBL] [Abstract][Full Text] [Related]
43. Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid. Davidson J; Turnbull C J Clin Psychopharmacol; 1982 Aug; 2(4):263-6. PubMed ID: 7119133 [No Abstract] [Full Text] [Related]
45. MBD children--variability in developmental patterns or growth inhibitory effect of stimulants? Kaffman M; Sher A; Bar-Sinai N Isr Ann Psychiatr Relat Discip; 1979 Mar; 17(1):58-66. PubMed ID: 287660 [No Abstract] [Full Text] [Related]
46. Evidence for in vivo methylation of the secondary amino antidepressant desipramine to imipramine in humans. Narasimhachari N; Saady JJ; Joseph A; Ettigi P; Friedel RO J Clin Psychopharmacol; 1982 Dec; 2(6):413-6. PubMed ID: 7174866 [No Abstract] [Full Text] [Related]
47. The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes. Weinberg WA; Brumback RA J Child Neurol; 1992 Oct; 7(4):431-45; discussion 446-61. PubMed ID: 1469255 [No Abstract] [Full Text] [Related]
48. Sudden death in children receiving Norpramin: a review of three reported cases and commentary. Riddle MA; Nelson JC; Kleinman CS; Rasmusson A; Leckman JF; King RA; Cohen DJ J Am Acad Child Adolesc Psychiatry; 1991 Jan; 30(1):104-8. PubMed ID: 2005044 [TBL] [Abstract][Full Text] [Related]
56. Depression in childhood: a biopsychosocial perspective. Lewis M; Lewis DO Am J Psychother; 1981 Jul; 35(3):323-9. PubMed ID: 6117207 [TBL] [Abstract][Full Text] [Related]
57. Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness. Watt DC; Crammer JL; Elkes A Psychol Med; 1972 Nov; 2(4):397-405. PubMed ID: 4571142 [No Abstract] [Full Text] [Related]
58. Potential mechanism of desipramine-related sudden death in children. Wagner KD; Fershtman M Psychosomatics; 1993; 34(1):80-3. PubMed ID: 8426895 [No Abstract] [Full Text] [Related]
59. Lack of weight gain under desipramine. Stern SL; Cooper TB; Johnson MH; Jones BA; Nelson LD; Smeltzer DJ Biol Psychiatry; 1987 Jun; 22(6):796-7. PubMed ID: 3593822 [No Abstract] [Full Text] [Related]
60. The diagnosis and treatment of hidden depression. Abroms GM Psychiatr Q; 1981; 53(4):235-41. PubMed ID: 7330133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]